ACVR1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.820800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.873800E-01
Normal-vs-Stage2
7.063600E-01
Normal-vs-Stage3
6.533800E-01
Normal-vs-Stage4
5.307800E-01
Stage1-vs-Stage2
3.653200E-01
Stage1-vs-Stage3
5.155000E-01
Stage1-vs-Stage4
1.393610E-01
Stage2-vs-Stage3
2.008600E-01
Stage2-vs-Stage4
3.786200E-01
Stage3-vs-Stage4
1.472950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.440600E-01
Normal-vs-AfricanAmerican
4.437000E-01
Normal-vs-Asian
8.220400E-01
Caucasian-vs-AfricanAmerican
2.856400E-01
Caucasian-vs-Asian
8.064600E-01
AfricanAmerican-vs-Asian
2.894400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.754400E-01
Normal-vs-Female
7.970400E-01
Male-vs-Female
7.262400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.852400E-01
Normal-vs-Age(41-60Yrs)
3.329000E-01
Normal-vs-Age(61-80Yrs)
9.762400E-01
Normal-vs-Age(81-100Yrs)
9.124000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.026400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.944400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.341200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.601200E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.027800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.371200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.856600E-01
Normal-vs-Daily Drinker
7.128200E-01
Normal-vs-Weekly Drinker
7.051400E-01
Normal-vs-Occasional Drinker
4.706400E-01
Normal-vs-Social Drinker
8.907000E-01
Non Drinker-vs-Daily Drinker
3.120000E-01
Non Drinker-vs-Weekly Drinker
1.637580E-01
Non Drinker-vs-Occasional Drinker
2.671500E-02
Non Drinker-vs-Social Drinker
3.931400E-01
Daily Drinker-vs-Weekly Drinker
2.600100E-02
Daily Drinker-vs-Occasional Drinker
1.938460E-03
Daily Drinker-vs-Social Drinker
9.357600E-02
Weekly Drinker-vs-Occasional Drinker
5.753200E-01
Weekly Drinker-vs-Social Drinker
6.567400E-01
Occasional Drinker-vs-Social Drinker
2.944800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.151000E-01
Normal-vs-Grade 2
5.324000E-02
Normal-vs-Grade 3
1.186380E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.790020E-02
Grade 1-vs-Grade 3
3.199700E-02
Grade 1-vs-Grade 4
5.151000E-01
Grade 2-vs-Grade 3
7.947600E-01
Grade 2-vs-Grade 4
5.324000E-02
Grade 3-vs-Grade 4
1.186380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.775400E-01
Normal-vs-NonDiabetic
8.049600E-01
Diabetic-vs-NonDiabetic
3.876200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.713400E-01
Normal-vs-NoPancreatitis
8.376000E-01
Pancreatitis-vs-NoPancreatitis
7.810400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.877400E-01
Normal-vs-N1
6.738600E-01
N0-vs-N1
1.287210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.683200E-01
Normal-vs-TP53-NonMutant
8.149400E-01
TP53-Mutant-vs-TP53-NonMutant
7.807000E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
